Loading stock research

Abiomed, Inc.

ABMD

HealthcareNASDAQUS

Sign in to save

$381.02

$0.00 (+0.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

ABMD News

News and disclosures filtered by period, publisher, and event group.

1 / 1

Filter options

Results

Select a headline to open the full news page in the app.

May 28, 2026, 1:26 PMprnewswire.comABMD

Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.

Company announcementsLegal proceedings

GOTHENBURG, Sweden, May 28, 2026 /PRNewswire/ -- Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed Inc ("Abiomed") in a patent dispute between Getinge's subsidiary Maquet Cardiovascular LLC ("Maquet") and Abiomed. The jury found that Abiomed has not infringed any Maquet patents relating to intravascular heart pump technology.

Loading disclosure news